Multicenter Validation of lncRNA and Target mRNA Diagnostic and Prognostic Biomarkers of Acute Ischemic Stroke From Peripheral Blood Leukocytes
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.124.034764 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Jialing Mu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Center for Global Health, School of Public Health Nanjing Medical University Nanjing Jiangsu China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Ischemic Stroke, RNA, Messenger, Leukocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Background Long noncoding RNA (lncRNA) and mRNA profiles in leukocytes have shown potential as biomarkers for acute ischemic stroke (AIS). This study aimed to identify altered lncRNA and target mRNA profiles in peripheral blood leukocytes as biomarkers and to assess the diagnostic value and association with AIS prognosis. Methods and Results Differentially expressed lncRNAs (DElncRNAs) and differentially expressed target mRNAs (DEmRNAs) were screened by RNA sequencing in the discovery set, which consisted of 10 patients with AIS and 20 controls. Validation sets consisted of a multicenter (311 AIS versus 303 controls) and a nested case–control study (351 AIS versus 352 controls). The discriminative value of DElncRNAs and DEmRNAs added to the traditional risk factors was estimated with the area under the curve. NAMPT‐AS , FARP1‐AS1 , FTH1 , and NAMPT were identified in the multicenter case–control study ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Center for Global Health, School of Public Health Nanjing Medical University Nanjing Jiangsu China.
- Department of Neurology The Affiliated Yixing Hospital of Jiangsu University Yixing Jiangsu China.
- Department of Cardiology The Affiliated Yixing Hospital of Jiangsu University Yixing Jiangsu China.
- Centre for Disease Control and Prevention Jurong Jiangsu China.
- Department of Neurology The Affiliated Hospital of Xuzhou Medical University Xuzhou Jiangsu China.
- Department of Neurology, Xuzhou Third People's Hospital Xuzhou Medical University Xuzhou Jiangsu China.
ORCID-Profile: Jialing Mu, Changying Chen, Fangyuan Liu, Junxiang Sun, Yu Liu, Deqin Geng, Xuemei Chen, Chong Shen
Zitieren
APA
Mu, J., Chen, C., Ren, Z., Liu, F., Gu, X., Sun, J., Liu, Y., Geng, D., Yang, S., Li, Q., Liu, L., Wang, L., Chen, X., Xie, H., & Shen, C. (2024). Multicenter Validation of lncRNA and Target mRNA Diagnostic and Prognostic Biomarkers of Acute Ischemic Stroke From Peripheral Blood Leukocytes. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.034764
Vancouver
Mu J, Chen C, Ren Z, Liu F, Gu X, Sun J, et al. Multicenter Validation of lncRNA and Target mRNA Diagnostic and Prognostic Biomarkers of Acute Ischemic Stroke From Peripheral Blood Leukocytes. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.034764
BibTeX
@article{Mu2024,
author = {Mu, Jialing and Chen, Changying and Ren, Zhanyun and Liu, Fangyuan and Gu, Xincheng and Sun, Junxiang and Liu, Yu and Geng, Deqin and Yang, Siyuan and Li, Qingqing and Liu, Lihua and Wang, Lu and Chen, Xuemei and Xie, Hankun and Shen, Chong},
title = {Multicenter Validation of lncRNA and Target mRNA Diagnostic and Prognostic Biomarkers of Acute Ischemic Stroke From Peripheral Blood Leukocytes},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.124.034764}
}
EUVIMED